NEWS for BIPH today:
Biophan CEO Michael Weiner to Present at ValueRich Small-Cap Financial Expo in Palm Beach on March 10
Wednesday March 9, 6:00 am ET
Company Chief to Outline Company's Advanced Biomedical Technologies and Business Strategy for Investment and Financial Community
ROCHESTER, N.Y.--(BUSINESS WIRE)--March 9, 2005-- Biophan Technologies, Inc. (OTCBB:BIPH - News), a developer of next-generation biomedical technology, has announced that it will be a presenting company at the ValueRich Small-Cap Financial Expo, a leading financial and investment industry conference, to be held in Palm Beach, Florida, March 9-12.
Biophan CEO Michael Weiner will discuss the Company's advanced biomedical technology-based solutions for products and product enhancements for important medical device market sectors.
Mr. Weiner's presentation will be webcast live on the Internet for viewing by interested investors. He is scheduled to begin his talk at 2:00 pm Eastern, on Thursday, March 10. To view the presentation, visit www.visualwebcaster.com/ValueRichExpo/. When the schedule of events appears, click on the Biophan company name. The presentation will be archived for 90 days following the event, and can be accessed at the same link as above.
The ValueRich Small-Cap Financial Expo is hosted by ValueRich Inc., publishers of ValueRich Magazine. The expo is a three-day conference that brings executives of small-cap companies together with investment professionals and the financial press. The ValueRich Small-Cap Financial Expo will be held in the new Palm Beach County Convention Center, in Palm Beach, Florida, and is expected to be the largest small-cap financial event ever held. Visit www.vrexpo.net for more information.
Biophan's cutting-edge research and development efforts include solutions to improve the safety, effectiveness, and image compatibility of medical devices used within Magnetic Resonance Imaging (MRI) environments. The Company has developed a variety of solutions in nanotechnology and other areas to create competitively advantageous product enhancements in several markets, including drug-elution technologies and implantable power systems powered by body heat.
Press Release Source: Biophan Technologies, Inc.
